FTQGX
Price
$33.58
Change
+$0.39 (+1.18%)
Updated
May 8 closing price
Net Assets
3.7B
VIGAX
Price
$199.59
Change
+$1.54 (+0.78%)
Updated
May 8 closing price
Net Assets
269.26B
Ad is loading...

FTQGX vs VIGAX

Header iconFTQGX vs VIGAX Comparison
Open Charts FTQGX vs VIGAXBanner chart's image
Fidelity Focused Stock
Price$33.58
Change+$0.39 (+1.18%)
VolumeN/A
Net Assets3.7B
Vanguard Growth Index Admiral
Price$199.59
Change+$1.54 (+0.78%)
VolumeN/A
Net Assets269.26B
FTQGX vs VIGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FTQGX vs. VIGAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTQGX is a Buy and VIGAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 269B vs. FTQGX (3.71B). VIGAX pays higher dividends than FTQGX: VIGAX (0.50) vs FTQGX (0.38). FTQGX was incepted earlier than VIGAX: FTQGX (29 years) vs VIGAX (25 years). FTQGX (0.61) is less costly to investors than VIGAX (0.05). FTQGX is a more actively managed with annual turnover of: 105.00 vs. VIGAX (11.00). FTQGX has a lower initial minimum investment than VIGAX: FTQGX (0) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 12.27 vs. FTQGX (-10.71). VIGAX return over 5 years is better than : 107.94 vs. FTQGX (30.39).
FTQGXVIGAXFTQGX / VIGAX
Total Expense Ratio0.610.051,220%
Annual Report Gross Expense Ratio0.610.051,220%
Fund Existence29 years25 years-
Gain YTD-12.335-6.235198%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.71B269B1%
Annual Yield % from dividends0.380.5076%
Returns for 1 year-10.7112.27-87%
Returns for 3 years25.1064.1339%
Returns for 5 years30.39107.9428%
Returns for 10 years73.27255.6929%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NIEAX17.06N/A
N/A
BNY Mellon International Equity A
LAVQX14.38N/A
N/A
Lord Abbett Fundamental Equity R2
FRBRX114.22N/A
N/A
Franklin Biotechnology Discovery R6
PEIJX38.38N/A
N/A
Principal Equity Income J
WXCRX12.95N/A
N/A
William Blair Emerg Mkts ex China Gr R6